GENMAB A/S (GMAB)
Clinical trial NCT04623541: enrollment: 195 → 194 participants.
Clinical trial NCT04623541: enrollment: 195 → 194 participants.
Clinical trial NCT03771859 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2025-12-30 → 2025-12-09 3. primary completion date: 2025-12-30 → 2025-12-09
Clinical trial NCT07436637: start date: 2026-05-30 → 2026-06-30.
Clinical trial NCT05952024 updates: 1. completion date: 2027-08-24 → 2029-04-22 2. primary completion date: 2027-08-24 → 2029-04-22
Clinical trial NCT05348733 updates: 1. completion date: 2026-12-15 → 2027-12-15 2. primary completion date: 2026-09-30 → 2027-09-01
Clinical trial NCT07595263: start date: 2026-06-15 → 2026-06-30.
Landsvirkjun’s first quarter results
Þriggja mánaða uppgjör Landsvirkjunar
Clinical trial NCT03320252: primary completion date: 2026-03-01 → 2026-04-22.
Clinical trial NCT06550076 updates: 1. completion date: 2026-05-07 → 2029-08-05 2. primary completion date: 2026-05-07 → 2029-08-05 3. enrollment: 1950 → 2099 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05161325 updates: 1. completion date: 2026-06-01 → 2027-03-31 2. primary completion date: 2025-12-31 → 2026-12-31
Clinical trial NCT06917079: enrollment: 387 → 665 participants.
Clinical trial NCT03876769: primary completion date: 2025-08-20 → 2027-10-19.
Clinical trial NCT07120945: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT07457086: status: NOT_YET_RECRUITING → RECRUITING.